Public Contracts Scotland · Contract
Enzyme Replacement Therapy Medicines
A public procurement published by City of Glasgow College via Public Contracts Scotland.
- —
- Award value
- —
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Contract
- Stage
Overview
Supply of Enzyme Replacement Therapy Medicines (a-d) to NHS Scotland: - NP92624(a) Laronidase 500units/5ml solution for infusion vials 1 vial (Aldurazyme®) - NP92624(b) Imiglucerase 400unit powder for solution for infusion vials 1 vial (Cerezyme®) - NP92624(c) Agalsidase beta 35mg powder for solution for infusion vials 1 vial (Fabrazyme®) - NP92624(c) Agalsidase beta 5mg powder for solution for infusion vials 1 vial (Fabrazyme®) - NP92624(d) Alglucosidase alfa 50mg powder for solution for infusion vials 1 vial (Myozyme®)
Key details
- Source
- Public Contracts Scotland
- Lifecycle stage
- Contract
- Status
- complete
- CPV classification
- 33600000
- Currency
- GBP
- Total award value
- —
- Tender value
- —
- First published
- 15 Aug 2024
- Last updated
- 15 Aug 2024
Awards
1 award recorded on this procurement.
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from City of Glasgow College
FAQs about this procurement
Who is the buyer for "Enzyme Replacement Therapy Medicines"?
Enzyme Replacement Therapy Medicines is a UK public-sector procurement published by City of Glasgow College via Public Contracts Scotland.
Has "Enzyme Replacement Therapy Medicines" been awarded?
Yes — 1 award is recorded. The current lifecycle stage is "Contract".
Which suppliers are involved in "Enzyme Replacement Therapy Medicines"?
1 supplier is linked: Softcat.
When was "Enzyme Replacement Therapy Medicines" published?
It was first published on 15 Aug 2024 and last updated on 15 Aug 2024, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable